Cancer News and Research

Latest Cancer News and Research

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells could become a potent way to tackle the disease, a leading Cancer Research UK scientist reveals at a conference in Glasgow today (Tuesday).

22 Jun 2004

Report shows the health of Australians continues to improve

A comprehensive report shows the health of Australians continues to improve and as a nation we are healthier than we’ve ever been.

21 Jun 2004

Cognitive decline can occur before chemotherapy treatment

In a series of studies in breast cancer patients, researchers at The University of Texas M. D. Anderson Cancer Center have confirmed the presence of “chemobrain” after chemotherapy treatment – but they also discovered that a significant portion of patients have cognitive declines even before chemotherapy.

21 Jun 2004

Cutting down on cigarettes may actually increase consumption of smoke, carbon monoxide and nicotine

Smokers who pride themselves on successfully cutting back as a step toward quitting tobacco altogether may be caught in a haze of self-deception.

21 Jun 2004

Paclitaxel analog kills more cancer cells than natural product

Paclitaxel, a natural compound from yew trees, is the world's best-selling anticancer drug. Several analogs are in clinical trial, with others in preclinical development. One problem that paclitaxel and all its analogs share, however, is that they are all highly complex compounds, and cannot be prepared synthetically in a commercially viable way.

21 Jun 2004

Class of molecules that could lead to treatments for a wide range of diseases, including cancer, arthritis, and heart disease

By making use of model compounds in drug design, chemists at the University of California, San Diego identified a class of molecules that could lead to treatments for a wide range of diseases, including cancer, arthritis, and heart disease.

21 Jun 2004

More than half of head and neck cancer patients disabled by cancer or by cancer treatment

According to information in the article, more than 40,000 new cases of head and neck cancer are diagnosed annually in the United States, with 12,000 deaths each year. Patients with head and neck cancer often experience problems with eating and communicating, have pain, and have poor emotional well being and general functional status.

21 Jun 2004

Targeting a gene that protects cancer cells from the lethal effects of radiotherapy could help improve the impact of treatment

Targeting a gene that protects cancer cells from the lethal effects of radiotherapy could help improve the impact of treatment, a leading Cancer Research UK scientist will tell conference delegates in Glasgow this week.

21 Jun 2004

Chemobrain side effect in women may be overestimated

A new study says the incidence of "chemobrain," a widely reported side effect in women undergoing treatment for breast cancer, may be overestimated.

21 Jun 2004

First license to begin research involving therapeutic cloning

A special licensing committee of the UK Human Fertilization & Embryology Authority (HFEA) met on June 16 in London to decide whether to grant a license to scientists at The Center for Life at Newcastle University.

20 Jun 2004

Drug for multiple sclerosis prevented disease development when tested on animal models

Scientists from the Neurological Sciences Institute at Oregon Health & Science University have shown that an investigative drug for multiple sclerosis and related diseases prevented disease development when tested on animal models.

20 Jun 2004

Early patient response to Forteo in postmenopausal women with osteoporosis

Changes in markers of bone remodeling after one month of treatment with FORTEO® (teriparatide [rDNA origin] injection) may provide important early evidence of treatment response, according to new data presented today at the 86th Annual Meeting of The Endocrine Society (ENDO).

17 Jun 2004

More precise and less invasive procedure for prostate cancer detection

Work by a University of Queensland researcher will make the trip to the doctor for a prostate cancer check a lot more appealing for men.

17 Jun 2004

Australian researchers awarded funding for new HIV vaccines

Australian researchers at Monash University have been awarded $488,125 in development grants by the National Health and Medical Research Council (NHMRC) for projects exploring new vaccines for HIV, the development of medical diagnostic devices and the development of drugs to treat metastatic cancers.

17 Jun 2004

Computer cluster helps understand how human cells and organs work

This will ultimately lead to more effective ways of treating cardiovascular disease and cancer as well as other diseases. It will also eventually allow doctors to tailor treatment in a way specific to that patient rather than a ‘one-size-fits-all’ approach.

17 Jun 2004

Ageing population will have serious implications for the provision of cancer services

Cancer Research UK is highlighting the issue at its inaugural Wales Against Cancer conference in Cardiff today, which aims to focus policy makers on improving cancer treatment and promoting lifestyle changes for cancer prevention.

17 Jun 2004

$2 million to advance medical research in Australia

Fourteen leading medical research teams across Australia have been granted $2 million by the Commonwealth Government to advance their medical research projects.

17 Jun 2004

Ultrasound technology to treat cancer

Ultrasound scans might be most familiar for getting a peek at a developing fetus, but the technology could also be used to treat cancer. A partnership between UC Davis, Siemens Medical Systems and ImaRx Inc., funded by a National Cancer Institute grant, will study ways to deliver drugs to tumors using focused ultrasound.

17 Jun 2004

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Labopharm Inc. today announced that it has entered into an agreement with Debiopharm S.A. under which Debiopharm has engaged Labopharm to conduct research on the potential oral delivery of a current intravenous cancer drug using Labopharm’s proprietary polymeric nano-delivery systems technology (also referred to as micelles technology).

16 Jun 2004

Soil-borne disease called allergic fungal sinusitis is on the rise

The bad news this summer is that a destructive, soil-borne disease called allergic fungal sinusitis (AFS) is on the rise -- at least according to the up tick in cases referred to specialist Steven Schaefer, MD, chairman of the Department of Otolaryngology at The New York Eye and Ear Infirmary.

16 Jun 2004

Cancer News and Research

Latest Cancer News and Research

Genetically engineering viruses to carry a suicide gene into ovarian cancer cells

Report shows the health of Australians continues to improve

Cognitive decline can occur before chemotherapy treatment

Cutting down on cigarettes may actually increase consumption of smoke, carbon monoxide and nicotine

Paclitaxel analog kills more cancer cells than natural product

Class of molecules that could lead to treatments for a wide range of diseases, including cancer, arthritis, and heart disease

More than half of head and neck cancer patients disabled by cancer or by cancer treatment

Targeting a gene that protects cancer cells from the lethal effects of radiotherapy could help improve the impact of treatment

Chemobrain side effect in women may be overestimated

First license to begin research involving therapeutic cloning

Drug for multiple sclerosis prevented disease development when tested on animal models

Early patient response to Forteo in postmenopausal women with osteoporosis

More precise and less invasive procedure for prostate cancer detection

Australian researchers awarded funding for new HIV vaccines

Computer cluster helps understand how human cells and organs work

Ageing population will have serious implications for the provision of cancer services

$2 million to advance medical research in Australia

Ultrasound technology to treat cancer

Research on the potential oral delivery of a current intravenous cancer drug using polymeric nano-delivery systems technology

Soil-borne disease called allergic fungal sinusitis is on the rise

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Cancer News and Research

Latest Cancer News and Research

Understanding the DNA Damage Response in Innate Immunity eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in